Integra Lifesciences Holdings (IART) Asset Writedowns and Impairment (2013 - 2025)
Integra Lifesciences Holdings recorded quarterly Asset Writedowns and Impairment of $511.4 million in Q2 2025, up 1420358.33% quarter-over-quarter from $36000.0 in Q4 2024, and up 10038.08% year-over-year from N/an in Q2 2024.
Integra Lifesciences Holdings' Asset Writedowns and Impairment history runs 9 years deep, the most recent figure standing at $511.4 million for Q2 2025.
- In Q2 2025, Asset Writedowns and Impairment rose 10038.08% year-over-year to $511.4 million; the TTM figure through Dec 2025 stood at $511.4 million (up 2552.31% YoY), while the FY2025 annual figure was $511.4 million, up 4088.43% from the prior year.
- Asset Writedowns and Impairment came in at $511.4 million for Q2 2025 at Integra Lifesciences Holdings, up from $36000.0 in the prior quarter.
- In the past five years, Asset Writedowns and Impairment ranged from a high of $511.4 million in Q2 2025 to a low of $36000.0 in Q4 2024.
- A 3-year average of $88.9 million and a median of $6.1 million in 2024 frame the typical range for Asset Writedowns and Impairment.
- On a YoY basis, Asset Writedowns and Impairment climbed as much as 10038.08% in 2025 and fell as far as 10038.08% in 2025.
- Integra Lifesciences Holdings' Asset Writedowns and Impairment stood at $2.8 million in 2021, then plunged by 98.69% to $36000.0 in 2024, then soared by 1420358.33% to $511.4 million in 2025.
- According to Business Quant data, Asset Writedowns and Impairment over the past three periods registered $511.4 million, $36000.0, and $7.1 million for Q2 2025, Q4 2024, and Q3 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Integra Lifesciences Holdings | 1.20 Bn | 939.16 Mn | 216.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 511.37 Mn |
| Jun 30, 2025 | 511.37 Mn |
| Dec 31, 2024 | 36,000.00 |
| Dec 31, 2024 | 36,000.00 |
| Sep 30, 2024 | 7.10 Mn |
| Sep 30, 2024 | 7.10 Mn |
| Jun 30, 2024 | 5.04 Mn |
| Jun 30, 2024 | 5.04 Mn |
| Mar 31, 2024 | 7.10 Mn |
| Mar 31, 2024 | 7.10 Mn |
| Mar 31, 2021 | 2.75 Mn |
| Mar 31, 2021 | 2.75 Mn |
| Jun 30, 2019 | 5.80 Mn |
| Jun 30, 2019 | 5.80 Mn |
| Dec 31, 2018 | 41,000.00 |
| Dec 31, 2018 | 41,000.00 |
| Sep 30, 2018 | 4.90 Mn |
| Sep 30, 2018 | 4.90 Mn |
| Sep 30, 2017 | 3.30 Mn |
| Sep 30, 2017 | 3.30 Mn |
| Dec 31, 2015 | 380,000.00 |
| Dec 31, 2015 | 380,000.00 |
| Sep 30, 2015 | -409,000.00 |
| Sep 30, 2015 | -409,000.00 |
| Mar 31, 2015 | 409,000.00 |
| Mar 31, 2015 | 409,000.00 |
| Dec 31, 2014 | 190,000.00 |
| Dec 31, 2014 | 190,000.00 |
| Mar 31, 2014 | 600,000.00 |
| Mar 31, 2014 | 600,000.00 |
| Dec 31, 2013 | -46.40 Mn |
| Dec 31, 2013 | -46.40 Mn |
| Sep 30, 2013 | 46.74 Mn |
| Sep 30, 2013 | 46.74 Mn |